NCT05200858View on ClinicalTrials.gov

Transcutaneous Electrical Nerve Stimulation (TENS) in Patients With Postacute Sequelae of Sars-CoV-2

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

December 1, 2023

Conditions
Postacute Sequelae of Sars-CoV-2Post-Acute COVID-19 SyndromeWidespread Chronic PainFatigue Syndrome, ChronicGait, Unsteady
Interventions
DEVICE

TENS - high-dose

Subjects will receive a functional TENS device (delivers 100% of the dose) to wear for 3-5 hours per day.

DEVICE

TENS - low-dose

Subjects will receive a placebo TENS device (delivers 10% of the dose) to wear for 3-5 hours per day.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

NeuroMetrix, Inc.
All Listed Sponsors
collaborator

NeuroMetrix, Inc.

INDUSTRY

lead

Baylor College of Medicine

OTHER